NCT06620575Completed
Evaluation of Predictive Factors for Recurrence of Persistent Atrial Fibrillation After Ablation
Source: ClinicalTrials.gov · Last updated 1 Oct 2024
Brief summary (registry, in English)
This is a single-center, retrospective, observational study based on data extracted from the medical records of patients who underwent a procedure for persistent atrial fibrillation ablation.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 542 (actual)
- First submitted
- 18 Sept 2024
- Start date
- 29 Mar 2023
- Primary completion date
- 30 Apr 2024
- Lead sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche
- Diseases
- Atrial fibrillation
- NCT number
- NCT06620575
What you commit to
- Study type: Observational
- Participants enrolled: 542
- From 29 Mar 2023 to the primary completion date, 30 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient under legal protection, guardianship, or conservatorship
- Patient who has expressed opposition to the use of their medical data (by completing and returning the opt-out form provided)
Who the study is looking for
- Patient aged 18 years or older, who has been informed about the research
- Patient who underwent a procedure for persistent atrial fibrillation ablation at Clairval Hospital since January 2014
- Patient for whom data regarding the ablation procedure are available
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hôpital Privé Clairval Coordinator of this site? Confirm its status | Marseille | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.